This document provides an overview and forecast of the global cervical cancer diagnostics market from 2012 to 2022. It analyzes the market size and growth by type of diagnostic test (Pap testing, HPV testing, colposcopy, cervical biopsies), age group (<35 years, 35+ years), region (North America, Europe, Asia Pacific, ROW), and key countries. The market is segmented by diagnostic type and age group, and market size and forecasts are provided for each segment from 2012-2022 at the global, regional, and country levels. Key companies operating in the market are also profiled.

1. Global Cervical Cancer Diagnostics Market By Type (Pap Testing, HPV
Testing, Colposcopy and Cervical Biopsies), By Age Group (<35 years,
35 years, >35 years): Forecast to 2022
• By Type - Pap Test, HPV Test, Colposcopy
and Cervical Biopsies.
• By Age Group – Below 35 years and 35
years and above.
• By Region- North America, Europe, Asia
Pacific, and ROW.
• By Country - U.S, Canada, Germany, U.K,
China, India, Mexico and Brazil.
January 2018

2. 2
 Global Cervical Cancer Diagnostics
Market – By Value (2012-16)
 Global Cervical Cancer Diagnostics
Market – By Value (2017-22)
 Global Cervical Cancer Diagnostics
Market Breakdown- By Type, By Value
 Pap Test
 HPV Test
 Colposcopy
 Cervical Biopsies
 Global Cervical Cancer Diagnostics
Market Breakdown-By Age Group, By
Value
 Below 35 years
 35 years and above
Global Coverage Regional Coverage
Global Cervical Cancer Diagnostics Market By Type (Pap Testing, HPV Testing, Colposcopy and Cervical
Biopsies), By Age Group (<35 years, 35 years, >35 years): Forecast to 2022
 Cervical Cancer Diagnostics
Market, (2012-2016)
 Cervical Cancer Diagnostics
Market, (2017-2022)
 By Value
 By Type, By Value
 By Age Group, By Value
 North America
 Europe
 Asia Pacific
 ROW
Country Coverage
 Cervical Cancer Diagnostics
Market (2012-2022)
 By Value
 By Type, By Value
 By Age Group, By Value
 U.S.
 Canada
 Mexico
 Brazil
 Germany
 U.K
 China
 India
Company Coverage
 Product Benchmarking
 Sales*
 Business Overview
 Recent Product Approvals
 Merger & Acquisition
*for listed companies only.
 Hologic, Inc.
 Abott Laboratories
 Roche Diagnostics
 Guided Therapeutics
 Becton, Dickinson and Company
 Qiagen
 Quest Diagnostics
 Arbor Vita Corporation
 g
 Global Coverage
 Regional Coverage
 Country Coverage
 Scope of the Study
Segment Coverage
 By Type
 By Age Group
 Region (North America, Europe, APAC and ROW)
 Country (U.S., Canada, Brazil, Mexico, Germany, U.K, China,
and India)

3. Table of Content
3
S.No Particulars Page No.
1. Research Methodology 20
2. Executive Summary 21
3. Strategic Recommendation 22
3.1 Increasing demand for HPV tests in global cervical cancer diagnostics market. 23
3.2
Asia Pacific Region to witness the fastest growth in cervical cancer diagnostics market in the forecast
period.
24
4. Cervical Cancer Outlook 25
5. Global Cervical Cancer Diagnostics Market: Growth and Forecast 38
5.1 By Value (2012-2016) 39
5.2 By Value (2017-2022) 40
6. Global Cervical Cancer Diagnostics Market – Segmental Analysis 47

4. Table of Content
4
S.No Particulars Page No.
6.1 Global Cervical Cancer Diagnostics Market Size, By Type: Breakdown (%) 47
6.1.1 Global Cervical Cancer Diagnostics Market Size, By Type, 2016 (%) 49
6.1.2 Global Cervical Cancer Diagnostics Market Size, By Type, 2022 (%) 50
6.1.3 Global Pap Test Market, By Value (2012-2022) 51
6.1.4 Global HPV Test Market, By Value (2012-2022) 52
6.1.5 Global Colposcopy Market, By Value (2012-2022) 53
6.1.6 Global Cervical Biopsies Market, By Value (2012-2022) 54
6.2 Global Cervical Cancer Diagnostics Market Size, By Age Group, Breakdown (%) 55
6.2.1 Global Cervical Cancer Diagnostics Market Size, By Age Group, 2016 (%) 56
6.2.2 Global Cervical Cancer Diagnostics Market Size, By Age Group, 2022 (%) 57

5. Table of Content
5
S.No Particulars Page No.
6.2.3
Global Cervical Cancer Diagnostics Market, By Age Group (Below 35 years), By Value
(2012-2022)
58
6.2.4
Global Cervical Cancer Diagnostics Market, By Age Group (35 years and above),
By Value (2012-2022)
59
7. Global Cervical Cancer Diagnostics Market: Regional Analysis 60
7.1 Global Cervical Cancer Diagnostics Market Size, By Region: Breakdown (%) 60
7.1.1 Global Cervical Cancer Diagnostics Market Size, By Region, 2016 (%) 61
7.1.2 Global Cervical Cancer Diagnostics Market Size, By Region, 2022 (%) 62
7.2 North America Cervical Cancer Diagnostics Market: Growth and Forecast 63
7.2.1 By Value (2012-2016) 64
7.2.2 By Value (2017-2022) 65
7.2.3 By Type, By Value (2012-2022) 71

6. Table of Content
6
S.No Particulars Page No.
7.2.4 By Age Group, By Value (2012-2022) 72
7.3 North America Cervical Cancer Diagnostics Market: Country Analysis (U.S and Canada) 73
7.3.1 U.S Cervical Cancer Diagnostics Market, By Value (2012-2022) 75
7.3.2 U.S Cervical Cancer Diagnostics Market, By Type, By Value (2012-2022) 77
7.3.3 U.S Cervical Cancer Diagnostics Market, By Age Group, By Value (2012-2022) 78
7.3.4 Canada Cervical Cancer Diagnostics Market, By Value (2012-2022) 80
7.3.5 Canada Cervical Cancer Diagnostics Market, By Type, By Value (2012-2022) 81
7.3.6 Canada Cervical Cancer Diagnostics Market, By Age Group, By Value (2012-2022) 82
7.4 Europe Cervical Cancer Diagnostics Market: Growth and Forecast 85
7.4.1 By Value (2012-2016) 86

7. Table of Content
7
S.No Particulars Page No.
7.4.2 By Value (2017-2022) 87
7.4.3 By Type, By Value (2012-2022)
94
7.4.4 By Age Group, By Value (2012-2022) 95
7.5 Europe Cervical Cancer Diagnostics Market: Country Analysis (Germany and U.K) 96
7.5.1 Germany Cervical Cancer Diagnostics Market, By Value (2012-2022) 98
7.5.2 Germany Cervical Cancer Diagnostics Market, By Type, By Value (2012-2022) 99
7.5.3 Germany Cervical Cancer Diagnostics Market, By Age Group, By Value (2012-2022) 100
7.5.4 U.K Cervical Cancer Diagnostics Market, By Value (2012-2022) 102
7.5.5 U.K Cervical Cancer Diagnostics Market, By Type, By Value (2012-2022) 103
7.5.6 U.K Cervical Cancer Diagnostics Market, By Age Group, By Value (2012-2022) 104

8. Table of Content
8
S.No Particulars Page No.
7.6 APAC Cervical Cancer Diagnostics Market: Growth and Forecast 106
7.6.1 By Value (2012-2016) 107
7.6.2 By Value (2017-2022) 108
7.6.3 By Type, By Value (2012-2022) 114
7.6.4 By Age Group, By Value (2012-2022) 115
7.7 APAC Cervical Cancer Diagnostics Market: Country Analysis (China and India) 116
7.7.1 China Cervical Cancer Diagnostics Market, By Value (2012-2022) 118
7.7.2 China Cervical Cancer Diagnostics Market, By Type, By Value (2012-2022) 119
7.7.3 China Cervical Cancer Diagnostics Market, By Age Group, By Value (2012-2022) 120
7.7.4 India Cervical Cancer Diagnostics Market, By Value (2012-2022) 122

9. Table of Content
9
S.No Particulars Page No.
7.7.5 India Cervical Cancer Diagnostics Market, By Type, By Value (2012-2022) 123
7.7.6 India Cervical Cancer Diagnostics Market, By Age Group, By Value (2012-2022) 124
7.8 ROW Cervical Cancer Diagnostics Market: Growth and Forecast 126
7.8.1 By Value (2012-2016) 127
7.8.2 By Value (2017-2022) 127
7.8.3 By Type, By Value (2012-2022) 129
7.8.4 By Age Group, By Value (2012-2022) 130
7.9 ROW Cervical Cancer Diagnostics Market: Country Analysis (Brazil and Mexico) 131
7.9.1 Brazil Cervical Cancer Diagnostics Market, By Value (2012-2022) 133
7.9.2 Brazil Cervical Cancer Diagnostics Market, By Type, By Value (2012-2022) 135

10. Table of Content
S.No Particulars Page No.
7.9.3 Brazil Cervical Cancer Diagnostics Market, By Age Group, By Value (2012-2022) 136
7.9.4 Mexico Cervical Cancer Diagnostics Market, By Value (2012-2022) 138
7.9.5 Mexico Cervical Cancer Diagnostics Market, By Type, By Value (2012-2022) 140
7.9.6 Mexico Cervical Cancer Diagnostics Market, By Age Group, By Value (2012-2022) 141
8. Global Cervical Cancer Diagnostics Market Dynamics 143
8.1 Global Cervical Cancer Diagnostics Market Drivers 144
8.2 Global Cervical Cancer Diagnostics Market Restraints 148
9. Global Cervical Cancer Diagnostics Market Trends 150
10. Porter Five Force Analysis 153
11. SWOT Analysis 155
10

11. Table of Content
S.No Particulars Page No.
12. Supply Chain Analysis 157
13. Pricing Analysis 159
14. Competitive Landscape: 164
14.1 Company Share Analysis of Key Industry Players 165
14.2 Product Benchmarking of Key Industry Players 167
14.3 Recent Product Approvals of Key Industry Players 169
15. Policy and Regulatory Landscape 170
16. Company Profiling 175
16.1 Hologic 176
16.2 Abott Laboratories 178
11

12. Table of Content
S.No Particulars Page No.
16.3 Roche 181
16.4 Guided Therapeutics 183
16.5 Becton, Dickinson and Company 185
16.6 Qiagen 187
16.7 Quest Diagnostics 189
16.8 Arbor Vita Corporation 191
17. About Us 192
12

13. List of Figures
Figure No. Figure Title Page No.
Figure 1: Global Cervical Cancer Diagnostics Market Size, By Value, 2012-2016 (USD Million) 39
Figure 2: Global Cervical Cancer Diagnostics Market Size, By Value, Forecast, 2017-2022 (USD Million) 40
Figure 3: Healthcare Costs Per Capita, By Select Countries, 2015 (USD) 41
Figure 4: World Female Population Estimates, 2017 (In Millions) 43
Figure 5: Age-Standardized Cervical Cancer Incidence Rate (per 100,000 women per year), By Region 43
Figure 6: Top 10 Most Frequent Cancer in Females, World, (Age−standardised incidence rate per 100,000 women) 44
Figure 7: Top 10 Most Frequent Cancer Deaths in Females, World, (Age−standardised incidence rate per 100,000
women)
44
Figure 8: Global Cervical Cancer Diagnostics Market Size, By Type, 2016 (%) 49
Figure 9: Global Cervical Cancer Diagnostics Market Size, By Type, 2022 (%) 50
Figure 10: Global PAP Test Market, By Value, 2012-2016 (USD Million) 51
Figure 11: Global PAP Test Market, By Value, 2012-2016 (USD Million) 51
Figure 12: Global HPV Test Market, By Value, 2012-2016 (USD Million) 52
Figure 13: Global HPV Test Market, By Value, Forecast, 2017-2022 (USD Million) 52
Figure 14: Global Colposcopy Test Market, By Value, 2012-2016 (USD Million) 53
Figure 15: Global Colposcopy Test Market, By Value, Forecast, 2017-2022 (USD Million) 53
Figure 16: Global Cervical Biopsies Market, By Value, 2012-2016 (USD Million) 54
Figure 17: Global Cervical Biopsies Market, By Value, Forecast, 2017-2022, (USD Million) 54
Figure 18: Global Cervical Cancer Diagnostics Market Size, By Age Group, 2016 (%) 56
Figure 19: Global Cervical Cancer Diagnostics Market Size, By Age Group, 2022 (%) 57
13

14. List of Figures
Figure No. Figure Title Page No.
Figure 20: Global Cervical Cancer Diagnostics Market, By Age Group (Below 35 years), By Value, 2012-2016 (USD Million) 58
Figure 21: Global Cervical Cancer Diagnostics Market, By Age Group (Below 35 years), By Value, Forecast, 2017-2022
(USD Million)
58
Figure 22: Global Cervical Cancer Diagnostics Market, By Age Group (35 years and above), By Value, 2012-2016 (USD
Million)
59
Figure 23: Global Cervical Cancer Diagnostics Market, By Age Group (35 years and above), By Value, Forecast, 2017-
2022 (USD Million)
59
Figure 24: Global Cervical Cancer Diagnostics Market Size, By Region, 2016 (%) 61
Figure 25: Global Cervical Cancer Diagnostics Market Size, By Region, 2022 (%) 62
Figure 26: North America Cervical Cancer Diagnostics Market Size, By Value, 2012-2016 (USD Million) 64
Figure 27: North America Cervical Cancer Diagnostics Market Size, By Value, Forecast, 2017-2022 (USD Million) 65
Figure 28: North America Healthcare Cost Per Capita, By Select Country, 2016 (USD) 66
Figure 29: North America GDP, 2012-2015 (USD Trillion) 66
Figure 30: North America GDP, By Select Country, 2016 (USD Trillion) 66
Figure 31: United States of America, Per Capita Expenditure on Healthcare, 2012-2016 (USD) 67
Figure 32: Canada, Per Capita Expenditure on Healthcare, 2012-2016 (USD) 67
Figure 33: United States of America, Female Population in the age group 15-64, 2012-2016 68
Figure 34: Canada, Female Population in the age group 15-64, 2012-2016 68
Figure 35: North America Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million) 71
Figure 36: North America Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million) 72
Figure 37: U.S. Cervical Cancer Diagnostics Market Size, By Value, 2012-2022 (USD Million) 75
Figure 38: U.S Health Spending, By Service or Product, 2016 (%) 76
Figure 39: U.S Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million) 77
14

15. List of Figures
Figure No. Figure Title Page No.
Figure 40: U.S Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million) 78
Figure 41: Canada Cervical Cancer Diagnostics Market Size, By Value, 2012-2022 (USD Million) 80
Figure 42: Canada Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million) 81
Figure 43: Canada Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million) 82
Figure 44: North America Cervical Cancer Diagnostics Market, Country Share, 2012-2016 (% of Total) 84
Figure 45: North America Cervical Cancer Diagnostics Market, Country Share, Forecast, 2017-2022 (% of Total) 84
Figure 46: North America Cervical Cancer Diagnostics Market, Country Share, Forecast, 2017-2022 (% of Total) 86
Figure 47: Europe Cervical Cancer Diagnostics Market Size, By Value, Forecast, 2017-2022 (USD Million) 87
Figure 48: Europe, GDP, By Select Country, 2016, (USD Billion) 89
Figure 49: Europe Health Spending Per Capita, By Select Country, 2016 (USD) 89
Figure 50: United Kingdom, Per Capita Expenditure on Healthcare, 2012-2016 (USD) 90
Figure 51: Germany, Per Capita Expenditure on Healthcare, 2012-2016 (USD) 90
Figure 52: United Kingdom, Female Population in the age group 15-64, 2012-2016 91
Figure 53: Germany, Female Population in the age group 15-64, 2012-2016 91
Figure 54: Europe Medical Technology Market Based on Manufacturer Prices, By Country, 2016 (%) 92
Figure 55: Europe Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million) 94
Figure 56: Europe Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million) 95
Figure 57: Germany Cervical Cancer Diagnostics Market Size, By Value, 2012-2022 (USD Million) 98
Figure 58: Germany Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million) 99
Figure 59: Germany Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million) 100
Figure 60: U.K Cervical Cancer Diagnostics Market Size, By Value, 2012-2022 (USD Million) 102
15

16. List of Figures
Figure No. Figure Title Page No.
Figure 61: U.K Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million) 103
Figure 62: U.K Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million) 104
Figure 63: Europe Cervical Cancer Diagnostics Market, Country Share, 2012-2016 (% of Total) 105
Figure 64: Europe Cervical Cancer Diagnostics Market, Country Share, Forecast, 2017-2022 (% of Total) 105
Figure 65: APAC Cervical Cancer Diagnostics Market Size, By Value, 2012-2016 (USD Million) 107
Figure 66: APAC Cervical Cancer Diagnostics Market Size, By Value, Forecast, 2017-2022 (USD Million) 108
Figure 67: APAC, GDP, By Select Country, 2016, (USD Billion) 110
Figure 68: APAC Health Expenditure Per Capita, Public and Private, By Select Country, 2016 (USD) 110
Figure 69: China, Female Population in the age group 15-64, 2012-2016 111
Figure 70: India, Female Population in the age group 15-64, 2012-2016 111
Figure 71: India, Degree of Urbanization, 2012-2016 (in %) 112
Figure 72: China, Degree of Urbanization, 2012-2016, (in %) 112
Figure 73: APAC Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million) 114
Figure 74: APAC Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million) 115
Figure 75: China Cervical Cancer Diagnostics Market Size, By Value, 2012-2022 (USD Million) 118
Figure 76: China Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million) 119
Figure 77: China Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million) 120
Figure 78: China Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million) 122
Figure 79: India Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million) 123
Figure 80: India Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million) 124
16

17. List of Figures
Figure No. Figure Title Page No.
Figure 81: APAC Cervical Cancer Diagnostics Market, Country Share, 2012-2016 (% of Total) 125
Figure 82: APAC Cervical Cancer Diagnostics Market, Country Share, Forecast, 2017-2022 (% of Total) 125
Figure 83: ROW Cervical Cancer Diagnostics Market Size, By Value, 2012-2016 (USD Million) 127
Figure 84: ROW Cervical Cancer Diagnostics Market Size, By Value, 2012-2016 (USD Million) 129
Figure 85: ROW Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million) 130
Figure 86: ROW Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million) 133
Figure 87: Brazil, Female Population in the age group 15-64, 2012-2016 134
Figure 88: Brazil, Degree of Urbanization, 2012-2016 (in %) 134
Figure 89: Brazil Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million) 135
Figure 90: Brazil Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million) 136
Figure 91: Mexico Cervical Cancer Diagnostics Market Size, By Value, 2012-2022 (USD Million) 138
Figure 92: Mexico, Female Population in the age group 15-64, 2012-2016 139
Figure 93: Mexico, Degree of Urbanization, 2012-2016 (in %) 139
Figure 94: Mexico Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million) 140
Figure 95: Mexico Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million) 141
Figure 96: ROW Cervical Cancer Diagnostics Market, Country Share, 2012-2016 (% of Total) 142
Figure 97: ROW Cervical Cancer Diagnostics Market, Country Share, Forecast, 2017-2022 (% of Total) 142
Figure 98: Global Cervical Cancer Diagnostics Market, By Company Share, 2016 (%) 165
Figure 99: Hologic, Revenue, 2013-2017 (USD Billion) 177
Figure 100: Hologic, Revenue, By Geography, 2017 (%) 177
17

18. List of Figures
Figure No. Figure Title Page No.
Figure 101: Hologic, Revenue, By Segment, 2017 (%) 177
Figure 102: Abbott Laboratories, Revenue, 2012-2016 (USD Million) 179
Figure 103: Abobott Laboratories, Revenue, By Segment, 2016 (%) 179
Figure 104: Abbott, Revenue, By Geography, 2016 (%) 180
Figure 105: Roche, Revenue, 2012-2016 (USD Million) 182
Figure 106: Roche, Revenue, By Segment, 2016 (%) 182
Figure 107: Roche, Revenue, By Geography, 2016 (%) 182
Figure 108: Guided Therapeutics, Sales, 2012-2016 (USD thousands) 184
Figure 109: BD, Revenue, 2012-2016 (USD Million) 186
Figure 110: BD, Revenue, By Geography, 2017 (%) 186
Figure 111: BD, Revenue, By Segment, 2017 (%) 186
Figure 112: Qiagen, Revenue, 2012-2016 (USD Millions) 188
Figure 113: Qiagen, Revenue, By Geography, 2016 (%) 188
Figure 114: Qiagen, Revenue, By Product Categories, 2016 (%) 188
Figure 115: Quest Diagnostics, Revenue, 2012-2016 (USD Millions) 190
Figure 116: Quest Diagnostics, Revenue, By Business Segments, 2016 (%) 190
18

19. List of Tables
Table No. Table Title Page No.
Table A: List of Abbreviations 26
Table B: Cervical Cancer Flowchart 34
Table C: Cervical Cancer Screening Recommendations 35
Table D: Cervical Cancer Diagnostics Segmentation Flowchart 37
Table E: Medical Tourism Market Drivers 42
Table F: Medical Tourism Index, By Region and Top Destinations 42
Table G: Recent Company Acquisitions in Cervical Cancer Diagnostics Market 46
Table H: HPV-Associated and HPV-Attributable Cancer Statistics, U.S, 2015 69
Table I: Major Players in cervical cancer diagnostics market in North America 83
Table J: Europe, Female Population aged 15+, By Region, 2017, (In Millions) 88
Table K: Major Players in cervical cancer diagnostics market in Europe 92
Table L: Pricing Analysis of PAP TEST 160
Table M: Pricing Analysis of HPV TEST 161
Table N: Pricing Analysis of Colposcopy Test 162
Table O: Pricing Analysis of Colposcopy Test 163
Table P: Roche, Growth Strategy 166
Table Q: Product Benchmarking of Key Industry Players, By Type 167
Table R: Product Benchmarking of Key Industry Players, By Type 168
Table S: Product Benchmarking of Key Industry Players, By Type 169
19

20. (c) AZOTH Analytics
For our study on Global Cervical Cancer Diagnostics Market, we have conducted comprehensive
secondary research followed by an extensive primary research. In the process of secondary research,
we have scrutinized industry documents, accessed from open sources, premium paid databases and
our internal knowledge base. In the process of primary research, we have interviewed various industry
experts across the value chain of the medical equipment and service industry.
Market size of the actual period (2012-2016) has been evaluated on the basis of growth trends of
the industry in the last five years, and confirming the findings through primary research. Annual
reports of the companies are scanned to further validate the market size and to estimate the size
of various other applications. Market sizing and growth in the forecast period (2017-2022) is
estimated through revenue mapping, growth of new advance equipment and technology and
historical growth pattern of the industry. All the relevant data points/ statistics in the forecast
period are validated through relevant and reliable primary sources.
Report Focus: Global Cervical Cancer Diagnostics Market.
- By Type (Pap Test, HPV Test, Colposcopy and Cervical Biopsies)
- By Age Group ( Below 35 years and 35 years and above)
- By Region (North America, Europe, Asia Pacific and ROW),
- By Country (U.S., Canada, Brazil, Mexico, Germany, U.K, China and India)
- Company Coverage (Roche, Hologic, Abott Laboratories, Guided Therapeutics, Qiagen, etc.)
Companies Contacted: Qiagen, Recombigen Laboratories
20
Research Methodology

21. Global Cervical Cancer Diagnostics Market Overview
Source: Azoth Analytics Estimates
xxxx
Xxxx
Xxxx
Xxxx
xxxx
Growing healthcare awareness in addition to increased expenditure in healthcare sector has been
boosting the global cervical cancer diagnostics market.
2012 2013 2014 2015 2016
Figure : Global Cervical Cancer Diagnostics Market Size, By Value, 2012-2016 (USD Million)
CAGR 2012-2016
xxxx%
21

22. Global Low Temperature Sterilization Market, By Value
22
Figure : Global Colposcopy Test Market, By Value,
2012-2016 (USD Million)
Source: Azoth Analytics Estimates
CAGR 2012-2016
xxxx%
CAGR 2017-2022
xxxx%
Figure : Global Colposcopy Test Market, By Value,
Forecast, 2017-2022 (USD Million)
2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022
Global Colposcopy Test Market
Xxxx
Xxxx
Xxxx
Xxxx
xxxx
xxxxx

23. Global Cervical Cancer Diagnostics Market- By Age Group
Figure : Global Cervical Cancer Diagnostics Market
Size, By Age Group, 2016 (%)
Female population aged 35 years and above held the major market share of approximately 74.44% in the
year 2016.
Below 35 years
35 years and above
Source: Azoth Analytics Estimates
Xxxx
xxxx
Xxxx
xxxx
Xxxx
xxxx
Key Drivers
23

24. Source: Azoth Analytics Estimates
Figure : U.K Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million)
CAGR 2012-2016
Pap Test : xx%
HPV Test : xx%
Colposcopy : xx%
Cervical Biopsies : xx%
U.K Cervical Cancer Diagnostics Market, By Type
Xxxx
xxxx
2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022
Pap Test HPV Test Colposcopy Cervical Biopsies
CAGR 2017-2022
Pap Test : xx%
HPV Test : xx%
Colposcopy : xx%
Cervical Biopsies : xx%
24
2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022
Pap Test
HPV Test
Colposcopy
Cervical Biopsies

25. Source: Azoth Analytics Estimates
Figure : ROW Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million)
CAGR 2012-2016
Below 35 years : xx%
35 years and above : xx%
ROW Cervical Cancer Diagnostics Market, By Age Group
Xxxx
Xxxx
xxxx
2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022
Below 35 years 35 years and above
CAGR 2017-2022
Below 35 years : xx%
35 years and above : xx%
25
2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022
Below 35 years
35 years and
above

26. About Azoth Analytics Pvt Ltd.
Azoth Analytics is a business research and analytics firm that creates in-depth research reports and provides customized research solutions and consultancy
services. Verticals in which Azoth Analytics specializes include healthcare and pharmaceutical, oil and gas, retail, chemicals, automotive, FMCG, food &
beverages and technology. Azoth creates comprehensive and in-depth research reports by recording, interpreting and analyzing information. Strategic
market sizing and data dredging techniques include secondary research, and primary research (interviews with management personnel and industry experts).
Related Reports:
Global Cancer Diagnostics Market: Trends, Opportunities and Forecasts (2016-2021)-(By Type: Imaging Tests, Endoscopy, Biopsy, Tumor
Marker; By Imaging Tests Sub-Type: MRI, Ultrasound, PET-CT Scan, Mammography; By Region: North America, Latin America, APAC,
Europe, MEA)
26